Chi-Med agrees R&D partnership with InmageneChina’s Chi-Med and Inmagene Biopharmaceuticals have agreed a strategic partnership to develop preclinical drug candidates for potential treatment Share XChi-Med agrees R&D partnership with Inmagenehttps://pharmaphorum.com/news/chi-med-agrees-rd-partnership-with-inmagene/
AstraZeneca files Imfinzi for groundbreaking lung cancer useAZ also unveils promising results from early-stage lung cancer combination Share XAstraZeneca files Imfinzi for groundbreaking lung cancer usehttps://pharmaphorum.com/news/az-files-for-us-early-lung-cancer-licence-for-imfinzi/